Last Updated 16 May 2022.
5 Vaccines Approved for Use in Poland
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 37 countries
15 trials in 12 countries
Approval Source: ema.europa.eu
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
63 trials in 22 countries
Approval Source: ema.europa.eu
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
78 trials in 26 countries
Approval Source: ema.europa.eu
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
21 trials in 23 countries
Approval Source: ema.europa.eu
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu
4 Vaccines in Clinical Trials in Poland
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
12 trials in 11 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
78 trials in 26 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
21 trials in 23 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries